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Phosphonates: Their Natural 
Occurrence and Physiological Role
Paweł Kafarski
Abstract
The first natural compound containing carbon-to-phosphorus bond—ciliatine 
was discovered 60 years ago, and for four decades, phosphonates were considered 
simply as a biological curiosity. Finding the importance of these compounds in 
biogeochemical phosphorus cycling, their role in methane production, as well as 
discovery of numerous phosphonates and phosphonopeptides of promising anti-
bacterial and antifungal activities has stimulated the development of studies on 
this class of compounds, especially on their metabolism and biochemistry. These 
studies are driven by the use of 31P NMR and by a clever combination of genomics 
and innovative chemistry by using the method of selective labeling of metabolites. 
These studies revealed unusual and interesting chemistry of these compounds.
Keywords: C—P bond, phosphonates, ciliatine, phosphonopeptides, mimetics, 
antibiotics, 31P NMR, genome mining
1. Introduction
Phosphonates are organophosphorus compounds characterized by a stable 
carbon-to-phosphorus (C—P) bond, which usually resists biochemical, thermal, 
and photochemical decomposition. The first phosphonate (compound 1, Figure 1), 
being an analog of β-alanine and taurine, was isolated in 1959 from ciliated protozoa 
in the rumen of sheep [1]. That was the cause why its discoverers—M. Horiguchi 
Figure 1. 
Ciliatine (2-aminoethylphosphonic acids) and its derivatives found in lipids, glycans, glycoproteins, and bile 
acids.
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and M. Kandatsu, named it ciliatine. This amino acid was then considered as a pos-
sible marker of the content of protozoa in sheep rumen, which appeared further to 
be misleading. For many years, natural compounds containing the C—P bond had 
been considered as curiosity being only scarcely studied. This is not the case in sci-
ence currently because of their involvement in the global phosphorus cycle and in 
oceanic methane production. Some aspects of their occurrence, environmental role, 
biochemistry, and biological functions have been reviewed [2–5]. This chapter will 
concentrate on discussion of chemical diversity of the naturally occurring phospho-
nates and on the indication of open problems, which have not yet been solved.
2. Occurrence of carbon-to-phosphorus bond
The discovery of ciliatine stimulated intensive studies on the distribution of 
phosphonates in nature. Despite the fact that early studies were hampered by 
the lack of simple and sensitive methods for the identification of the presence of 
carbon-to-phosphorus bond in natural samples, it was found to exist in protozoa, 
bacteria, coelenterates, and mollusks [6–11]. Presumably, the unbreakable record 
is held by the snail Helisoma sp. freshly laid eggs, which contain over 95% of total 
phosphorus in phosphonate form [12]. Upon embryonic development, phosphonate 
is converted into phosphoric acid and subsequently incorporated into cellular con-
stituents. It is believed that the physiological role of incorporation of phosphonates 
into the lipid fraction might function as a means to protect the eggs against preda-
tors, because they are presumably not able to disrupt and digest such membranes.
The advent of 31P NMR for the analysis of tissue extracts, body fluids, and 
later—whole cells provided an effective tool for tracking the forms of phosphorus 
and its interchanges during organism development and growth. Quite paradoxi-
cally, the availability of 31P NMR was accompanied with a significant decrease in 
the number of papers dealing with distribution of phosphonates in various species. 
Applications of this simple technique enabled the determination of the presence 
of C—P bond in bacteria and bacterial communities [13, 14], cyanobacteria [15], 
sponges [16], higher fungi [17, 18], or even human specimens [19]. However, these 
studies did not explain if phosphonates are synthesized de novo or are introduced to 
these organisms by cohabiting organisms or diet. On the other hand, phosphonate 
xenobiotics are quite massively released into environment [20], and various organ-
isms might use them, or products of their decomposition, as building blocks of 
more complex structures.
Next, gene-based methods for assessing the abundance and identity of bio-
logical phosphonate producers were applied. This approach based on knowledge 
regarding C—P compound biosynthesis. Thus, with a single exception [21], all the 
known phosphonates are derived from phosphoenolpyruvate by isomerization to 
phosphonopyruvate in a reaction catalyzed by the phosphoenolpyruvate mutase, 
followed by its fast utilization because the reaction of formation of the C—P bond 
is thermodynamically unfavorable (see Figure 3). Most common, decarboxylation 
of phosphonopyruvate by phosphonopyruvate decarboxylase to produce phospho-
noacetaldehyde is the next, irreversible step [3, 22–24]. Mining in genome databases 
for genes related to these two enzymes, as well as their homologs, enabled to deter-
mine that 10–15% of bacterial species are able to produce phosphonates [23–25].
Discovery that phosphonates form around 10% of dissolved and particulate 
phosphorus in the oceans [15, 25, 26] brought the increasing recognition of the 
importance of these compounds in biogeochemical phosphorus cycling and an 
awareness of the interdependence between the global phosphorus cycle and those 
of the other biologically significant elements [27, 28]. It is important because 
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phosphorus availability has been shown to be a key determinant of marine phy-
toplankton productivity [15]. Phosphonates are mostly concentrated in dissolved 
organic phosphorus (DOP), an integral and dynamic part of the marine organic 
matter pool. The composition of the DOP pool is complex and largely unknown, 
but phosphonates account for one third of its high molecular weight fraction. 
Thus, they seem to be an important resource of this element for aquatic organ-
isms; however, the understanding of their utilization by eukaryotic phytoplankton 
is severely limited [29, 30]. They most likely occur in a form of polysaccharides 
esterified with methylphosphonate (compound 2, Figure 1) and 2-hydroxyeth-
ylphosphonate (compound 3, Figure 1). These compounds have been mainly found 
in Nitrosopumilus maritimus, one of the most abundant organisms on the planet and 
a resident of the oxygen-rich regions of the open oceans [31, 32].
Up to 4% of the methane on Earth comes from the oxygen-rich waters through 
the cleavage of the highly unreactive carbon-to-phosphorus bond in methyl phos-
phonate [32]. The production of methylphosphonic acid (MPn) by cyanobacteria 
or marine archaea related to N. maritimus and its subsequent decomposition by 
phosphate-starved bacterioplankton may partially explain the production of 
methane in oceanic and lake surfaces [33–35]. The concentration of methane in the 
upper ocean being above equilibrium with the atmosphere is known as the oceanic 
methane paradox [36, 38].
Some researchers believe that phosphonates are a form of relic of evolution. 
Being of slightly lower formal oxidation state, they might predominate in prebiotic 
reductive conditions [37]. This assumption, although debatable, finds some support 
by finding several phosphonic acids in Murchison meteorite [39].
3. Ciliatine (AEP, 2-aminoethylphosphonic acid)
Ciliatine (compound 1) is the most ubiquitous phosphonate present in lower 
organisms and occurs in remarkably high amounts. It is either presented in a 
free, unbound form being a common intermediate in numerous phosphonate 
biosynthetic pathways or incorporated into lipids and glycans. It is not surpris-
ing if considering that ciliatine is a formal analog of common component of 
lipids—phosphoethanolamine (compound 4). Most of the studies on natural 
occurrence of ciliatine and its lipids had been published in 1960–1990 and are 
comprehensively reviewed [2–5]. Only single paper was published after this period. 
As shown in Figure 1, its methylated forms, namely N-methyl, N,N-dimethyl-, 
and N,N,N-trimethylciliatine (compounds 5, 6, and 7), were also found in lipid 
fractions of some organisms albeit in significantly smaller quantities. Compound 
7 is an analog of the most common component of lipids—phosphocholine 
(compound 8). The presence of an unusual aminophosphonate—(R)-2-amino-
1-hydroxyethylphosphonic acid (compound 9) and its acetyl derivative has been 
determined in lipid fractions of Bacteriovorax stolpii [40, 41]. Its configuration was 
elegantly determined by a combination of chemical synthesis and biochemical 
studies [42].
Lipids containing aminophosphonates are called phosphonolipids. There are two 
classes of these compounds—glycerophosphonolipids and sphingophosphonolipids 
(representative structures are shown in Figure 2). They have been isolated from 
numerous organisms including humans, mammals (sheep, goats, and rats), egg 
yolk, fish, insects, sea anemones, sponges, numerous species of freshwater and 
marine mollusks, seeds of plants, protozoa, and bacteria [3, 43–46]. Usually they 
are a small fraction of the total lipids present, and their isolation and exact identifi-
cation/characterization are difficult and cumbersome.
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Figure 2. 
Representative structures of phosphonolipids, phosphonoglycans, and phosphonosteroid.
The physiologic function of phosphonolipids is still unknown, and the suggested 
protecting role against predators resulting from their stability toward hydrolysis 
by lipases and phosphatases has not been proved so far. Moreover, the distribution 
and abundance of phosphonolipids among organisms vary with species, tissue, or 
cellular location. For example, vertebrates have sphingophosphonolipids as compo-
nents of nervous tissue sphingomyelin, while invertebrates frequently contain high 
levels of these lipids as outer membrane components.
Whereas phosphate is a common modification of polysaccharides, there are only 
a few examples of polysaccharides containing phosphonate moieties. Their char-
acterization/identification was made possible as well as substantially accelerated 
by the development of glycomics [47]. Ciliatine and compound 9 have been found 
to be bound to the sugar moieties of variable glycans (see Figure 2 for schematic 
structures). Their occurrence was documented in fractions of glycocerebrosides 
(lipids) of many lower marine phyla [2, 12, 48], bacterial exopolysaccharides 
(secreted polysugars into the environment), and outer membrane components 
5Phosphonates: Their Natural Occurrence and Physiological Role
DOI: http://dx.doi.org/10.5772/intechopen.87155
[49–51] and glycoproteins deriving from marine snails, common jellyfish and locust 
[51–54]. Genome scanning led to the identification of methylphosphonic acid 
(compound 2) in the exopolysaccharide of the marine archeon N. maritimus. Its 
function is not known, but it is ultimately a major source of methane production by 
the oceans [32].
Similarly as in the case of phosphonolipids, the physiological role of phospho-
noglycans is not known and thus awaits determination. This might be important 
in the context that the glycans are essential molecules being well known to enable 
adaptive response to environmental changes [55]. The speculative roles of phospho-
noglycans include cell-cell signaling or their action as phosphorus reservoirs in the 
environments of low phosphate concentration. The second assumption might be 
supported by the conservation of phosphonolipids at the expense of phosphodies-
ters in starved conditions by the oyster Crassostrea virginica [56]. Other possibility is 
demonstrated by the fact that Bacteroides fragilis, a part of the normal microbiota of 
the human colon, produces a capsular polysaccharide complex containing ciliatine, 
which is directly involved in abscess formation in animal models when bacteria are 
displaced into the bloodstream [57].
It is also important to mention that the phosphonic analog of taurocholic acid 
was found in the gall bladders of cows [58]; however, this finding may require 
additional confirmation.
4. Low-molecular phosphonates metabolically related to ciliatine
Biosynthesis of phosphonates starts from rearrangement of phosphoenolpyru-
vate (compound 10) into phosphonopyruvate (compound 11), a reaction catalyzed 
by phosphonoenolpyruvate mutase. In this equilibrium process, the thermody-
namics favors phosphonoenolpyruvate by a factor of at least 500. Thus, phos-
phonopyruvate has to be rapidly converted into metabolically useful compounds, 
most favorably in the irreversible reactions. Consequently, it is a key substrate 
in the synthesis of ciliatine (compound 1), phosphonoalalnine (compound 12), 
2-hydroxyethylphosphonic acid (compound 3), phosphonoacetaldehyde (com-
pound 13), phosphonomethylmalic acid (compound 14), and 2-keto-4-hydroxy-
5-phosphonopentanoic acid (compound 15). Most of the enzymes involved in the 
production of these compounds have been isolated and characterized and compre-
hensively reviewed [2, 59]. The metabolic relationships between these compounds 
and their precursor role in the synthesis of phosphonate antibiotics are shown in 
Figure 3.
Low-molecular antibiotics such as fosfomycin (compound 17) [60], fosfonochlo-
rin (compound 18 produced by several strains of Fusarium and Talaromyces flavus) 
[61], nitrilaphos and hydroxynitrilaphos (compounds 19 and 20 found in cultivat-
ing media of Streptomyces) [62], and herbicidal phosphonothrixin (compound 21, 
produced by Saccharothrix) [63] might be also considered as low-molecular com-
pounds related to ciliatine.
Only one of them—fosfomycin (also known as Monuril, Monurol, or Monural), 
produced by Pseudomonas and Streptomyces, has found limited use as therapeutic 
agent to cure urinary tract infections and diabetic foot [60]. It is an active site 
directed covalent inactivator of muramyl ligase A, the first enzyme of peptidogly-
can synthesis, and causes disruption of bacterial cell wall. Unfortunately, bacteria 
adapted to be able to open the epoxy ring functionality of fosfomycin, thus result-
ing in the compound deactivation/degradation of this antibiotic and in the microor-
ganism ability to readily develop drug resistance [64]. Quite interestingly, pathways 
for the biosynthesis of fosfomycin in Streptomyces and Pseudomonas are different 
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(see Figure 3). This shows that synthesis of natural phosphonates does not have to 
be normalized; many metabolic pathways are still yet to be discovered.
The separate class is aminophosphonate antibacterial antibiotics possessing an 
amino group in the gamma position in relation to the phosphonic functional group, 
namely fosmidomycin (compound 22), and its derivatives denoted as FR900098 
(compound 23), FR-33289 (compound 24), and FR32863 (compound 25), origi-
nally isolated from culture broths of Streptomyces as well as cyclic SF2312 (com-
pound 26) isolated from Micromonospora sp. [65–67]. Their structures are shown in 
Figure 4.
Fosmidomycin and its homologs are potent inhibitors of 1-deoxy-d-xylulose-
5-phosphate reductoisomerase, an essential enzyme of the non-mevalonate path-
way of isoprenoid biosynthesis being active against a broad range of enterobacteria, 
Figure 4. 
Antibiotics structurally related to fosmidomycin.
Figure 3. 
Metabolic relationship between naturally occurring phosphonates.
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but not against Gram-positive organisms or anaerobes. More importantly, they are 
blocking the development of isoprenoids in the parasite apicoplast, and thus, struc-
turally modified fosmidomycin derivatives are considered as promising antimalarial 
agents (for representative structure, see Figure 4) [68].
Aphanizomenon flos-aquae is a cyanobacterium that grows in eutrophic Balgavies 
Loch in Scotland. From its water blooms, a novel biosurfactant of lipidic charac-
ter—2-acyloxyethylphosphonate (compound 27) was isolated; however, its ecologi-
cal function remains to be evaluated [69].
Two unusual placotylene A esters [69] of ciliatine (phosphoiodyn A, compound 
28) and its phosphate congener—phosphoethanolamine (phosphoiodyn B) were 
isolated from a Korean marine sponge Placospongia sp. [70]. Phosphoiodyn A was 
found to exhibit a potent agonistic activity on human peroxisome proliferator-
activated receptor delta (hPPARδ), which is thought to function as an integrator of 
transcriptional repression and nuclear receptor signaling [16, 71]. This compound, 
as well as its analogs, demonstrates significant neuroprotective activity in an in vitro 
cellular model indicating that such phosphonates may be an effective novel scaffold 
for the design of therapeutics for the treatment of neurodegenerative disorders [71].
5. Phosphonopeptide antibiotics
Half of the century after the discovery of ciliatine witnessed a slow progress in 
the isolation and identification of natural compounds containing the C—P bond 
with most of them being antibacterials. The majority of these compounds appeared 
to be peptides containing C-terminal phosphonic acids and mostly differ by their 
N-terminal peptide structure. They have drawn attention not only because of their 
bioactivity but also because of unusual and interesting chemistry associated with 
the biosynthesis and biodegradation of these molecules. Structures of antibiotic 
phosphonopeptides are shown in Figure 5.
Bialaphos (compound 29, [72]) was isolated from as the first such an antibi-
otic from the culture filtrates of Streptomyces viridochromogenes and Streptomyces 
hygroscopicus [72–74]. Further studies indicated that its antibacterial activity is a 
result of active transport of the peptide across bacterial membrane followed by 
hydrolysis of the peptide and release of terminal phosphonate—phosphinothri-
cin, which inhibits glutamine synthetase. This enzyme converts glutamic acid 
and ammonia into glutamine; this reaction is an important step of the nitrogen 
metabolism in bacteria and plants [75]. That activity of phosphinothricin resulted 
in its introduction to agriculture as a popular herbicide, and it is sold as ammo-
nium salt under the name glufosinate. Its application causes accumulation of 
ammonia in plants and consequently plant death [76]. It is worth to notice that 
bialaphos also exerts herbicidal activity and was applied in Japan [77]. Its activity 
relays on hydrolysis of bialaphos in plant tissues and release of herbicidal phos-
phinothricin. Further studies on bialaphos resulted in isolation of tetrapeptide 
trialaphos (compound 30) [78] and phosalacine (compound 31) [79] both of the 
same mechanism of action. Finally, studies on biosynthesis of this compound 
resulted in the identification of its desmethyl analog 32, which is an intermediate 
in bialaphos metabolism.
The antibacterial activity of bialaphos is typical for all the phosphonopeptides. 
Peptide parts of these antibiotics usually function as a targeting unit. Thus, the 
peptides are efficiently transported through bacterial (or fungal) membranes and 
after hydrolysis release phosphonic acid, which exerts its toxic action by inhibit-
ing parasite vital enzymes—in this case glutamine synthetase. This mechanism of 
action is shown schematically in Figure 6.
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The following years brought the discovery of a family of antibiotics called 
rhizocticins (compounds 33–36) [80, 81], plumbemycins (compounds 37 and 
38) [81–83], and phosacetamycin (compound 39) [84], first isolated as secondary 
metabolites of Bacillus subtilis on the basis of their antifungal activity and were 
Figure 5. 
Phosphonopeptide antibiotics.
Figure 6. 
Representative mechanism of action of phosphonopeptides.
9Phosphonates: Their Natural Occurrence and Physiological Role
DOI: http://dx.doi.org/10.5772/intechopen.87155
later found as products of Streptomyces plumbeus. They form a library of di- and 
tripeptides containing C-terminal (Z)-L-2-amino-5-phosphono-3-pentenoic acid, 
a mimetic of phosphonothreonine, which is the substrate for threonine synthetase. 
Thus, after the release from the peptide aminophosphonate acts as a potent inhibi-
tor of this enzyme [85].
Dehydrophos (compound 40) was first isolated from the broth of Streptomyces 
luridus as a broad-spectrum antibiotic affective in chicken model of Salmonella 
infection [86]. The history of determination of its structure is rather long and led 
to three propositions of which the last one appeared to be reasonable and compel-
ling. It is a dehydrophosphonopeptide, which, after the cleavage of the peptide 
bond, provides an analog of dehydroalanine, which is then converted into methyl 
acetylphosphonate (compound 41, an analog of pyruvic acid), which is strongly 
antibacterial by acting most likely as antimetabolite of pyruvate (Figure 6) [87]. 
Thus, it was considered as a lead compound for the design of novel antibacterial 
agents [88]. The non-typical and innovative is the application of its biosynthetic 
enzymes for obtaining new antibacterial phosphonopeptides [89]. Recently, the role 
of nonribosomal peptidyl transferase DhpH in the formation of peptide bond in 
dehydrophos was studied in detail using phosphonic analog of alanine and various 
amino acid-tRNAs as substrates [90].
Phosphonopeptides have very limited utility in human medicine because they 
are readily hydrolyzed in body fluids and released aminophosphonic acids that 
are not able to cross bacterial or fungal cell barriers and to exert antibiotic action. 
Additionally, they are being readily excreted through urine.
Published in 2015 work of Metcalf and van der Donk brought a significant 
breakthrough in studies on naturally occurring phosphonate antibiotics. By a 
clever combination of the mining of the genome of 10,000 of actinomycetes and 
selective labeling of phosphonate metabolites, they rediscovered a large number 
of old phosphonates and discovered 19 new compounds [24]. This opened a 
genetic approach in natural phosphonate chemistry and biochemistry, espe-
cially enabling the identification of metabolic pathways leading to this class of 
compounds. An important and instructive example here is an activation of gene 
cluster from Streptomyces sp. NRRL F-525 and its reengineering in Streptomyces 
lividans, which resulted in the isolation of O-phosphonoacetic acid serine (com-
pound 42) [91].
One of the examples of rediscovered compounds is fosfazinomycins A and B 
(compounds 43 and 44), identified 30 years after their original isolation from 
Streptomyces lavendofoliae and Streptomyces unzenensis [92, 93]. They are a very 
specific since they contain an exotic structural feature, which is the hydrazide 
linkage between the carboxylic acid of peptidyl arginine and the phosphonic acid. 
Fosfazinomycin was also found further in one of 210 substances present in 42 
actinomycetes associated with the Baltic sponge Halichondria panacea [94].
The genetic approach also enabled the isolation and characterization of novel of 
Streptomyces peptidomimetics such as argolaphos A and B (compounds 45 and 46) 
and valinophos (compound 47) [24]. Similar approach was used for the isolation 
of phosphonocystoximate and its hydroxylated derivative (compounds 48 and 49) 
[24]. Detailed NMR studies on their biosynthesis, which starts from ciliatine and 
its analog—compound 9, enabled to confirm the presence of intermediates such 
as mixtures of the (E)- and (Z)-isomers of corresponding oximes (compounds 50 
and 51), substrates for the synthesis of phosphonocystoximate and its hydroxyl-
ated derivative [95]. They are formed by the action of specific flavin-dependent, 
oxime-forming N-oxidases. These oxidases are also able to convert the oximes 50 
and 51 into corresponding nitroethylphosphonates (compounds 52 and 53) [96]. 
Structures of these intermediates and side products are depicted in Figure 7.
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A separate group of phosphonic peptidomimetics is compounds denoted as 
K-26, K4, and I5B2 (compounds 54, 55, and 56, respectively) [21, 97–99], a small 
family of bacterial secondary metabolites, tripeptides terminated by an unusual 
phosphonate analog of tyrosine (see Figure 6). They are produced by three differ-
ent actinomycetales and act as potent inhibitors of human angiotensin-I converting 
enzyme selectively targeting the eukaryotic family of the enzyme [100, 101]. These 
compounds derived from L-tyrosine, which suggests the existence of novel and not 
discovered yet reaction of carbon-to-phosphorus bond formation [21, 102].
6. Conclusions
Natural phosphonates might be considered as simple analogs of phosphate 
esters and/or carboxylic acids. The inherent stability of the C—P bond causes that 
they often display promising activities as enzyme inhibitors and therefore might 
be considered as drugs or agrochemicals. Moreover, the wide use of xenobiotics 
containing carbon-to-phosphorus bond has led to the spread of these compounds 
in the environment, which may result in their incorporation into variable metabolic 
pathways. All of this stimulate interest in these, still somewhat exotic, compounds. 
The development of 31P NMR and genomics supplemented by biochemical stud-
ies resulted in the development of new detection technologies, which enormously 
speed out the discovery of novel naturally occurring phosphonates, identification 
of their metabolic pathways (both biosynthesis and degradation), and their use as 
lead compounds for the design of new promising medicines. With the exception of 
the identification of antibacterial and antifungal antibiotics, these studies are not 
accompanied, however, with the determination of physiologic importance of these 
compounds.
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Intermediates and side products in the synthesis of phosphonocystoximate.
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